Literature DB >> 25762122

Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Noriaki Yoshida1, Dai Chihara.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a mature T-cell neoplasm with extremely poor prognosis caused by human T-cell leukemia virus type 1 (HTLV-1). The distribution of HTLV-1 and the incidence of ATLL in endemic areas have been well described, however, little is known about the incidences and the trends of the disease in nonendemic areas. Recently, studies have shown that the HTLV-1 carriers are increasing in nonendemic areas. Also, the incidence of ATLL seems to be significantly increasing in nonendemic areas suggesting that HTLV-1 carriers have emigrated from endemic areas. These epidemiologic studies indicate the necessity of edification of the disease caused by HTLV-1 and establishing appropriate preventive methods against infection in nonendemic areas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25762122     DOI: 10.1007/s11864-014-0321-5

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  52 in total

1.  Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group.

Authors:  T Takezaki; K Tajima; M Ito; S Ito; K Kinoshita; K Tachibana; Y Matsushita
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

2.  Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type I-infected T cell lines.

Authors:  R Trovato; A Cereseto; S Takemoto; A Gessain; T Watanabe; T Waldmann; G Franchini
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-20       Impact factor: 2.205

3.  Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.

Authors:  Masako Iwanaga; Toshiki Watanabe; Atae Utsunomiya; Akihiko Okayama; Kaoru Uchimaru; Ki-Ryang Koh; Masao Ogata; Hiroshi Kikuchi; Yasuko Sagara; Kimiharu Uozumi; Manabu Mochizuki; Kunihiro Tsukasaki; Yoshio Saburi; Masaomi Yamamura; Junji Tanaka; Yukiyoshi Moriuchi; Shigeo Hino; Shimeru Kamihira; Kazunari Yamaguchi
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

Review 4.  [Lymphoma and immunoglobulin abnormalities, with special reference to M proteinemia].

Authors:  K Takatsuki; T Uchiyama; K Sagawa; T Hattori
Journal:  Nihon Rinsho       Date:  1977

5.  Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain.

Authors:  Ana Treviño; Luiz Carlos Alcantara; Rafael Benito; Estrella Caballero; Antonio Aguilera; José Manuel Ramos; Carmen de Mendoza; Carmen Rodríguez; Juan García; Manuel Rodríguez-Iglesias; Raúl Ortiz de Lejarazu; Lourdes Roc; Patricia Parra; José Eiros; Jorge del Romero; Vincent Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-09       Impact factor: 2.205

6.  Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.

Authors:  Masahiro Satake; Kazunari Yamaguchi; Kenji Tadokoro
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

7.  Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

Authors:  D Catovsky; M F Greaves; M Rose; D A Galton; A W Goolden; D R McCluskey; J M White; I Lampert; G Bourikas; R Ireland; A I Brownell; J M Bridges; W A Blattner; R C Gallo
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

8.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Mutations of the p53 gene in adult T-cell leukemia.

Authors:  A Sakashita; T Hattori; C W Miller; H Suzushima; N Asou; K Takatsuki; H P Koeffler
Journal:  Blood       Date:  1992-01-15       Impact factor: 22.113

10.  Identification of multiple subclones in peripheral T-cell lymphoma, not otherwise specified with genomic aberrations.

Authors:  Noriaki Yoshida; Akira Umino; Fang Liu; Kotaro Arita; Kennosuke Karube; Shinobu Tsuzuki; Koichi Ohshima; Masao Seto
Journal:  Cancer Med       Date:  2012-09-26       Impact factor: 4.452

View more
  5 in total

Review 1.  T-cell Lymphoma Epidemiology: the Known and Unknown.

Authors:  Anh Phan; Rachel Veldman; Mary Jo Lechowicz
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952

2.  Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Authors:  Janice P Dutcher; Peter H Wiernik; Leticia Varella; Rangaswamy Chintapatla
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.

Authors:  Adrienne A Phillips; Paul A Fields; Olivier Hermine; Juan C Ramos; Brady E Beltran; Juliana Pereira; Farooq Wandroo; Tatyana Feldman; Graham P Taylor; Ahmed Sawas; Jeffrey Humphrey; Michael Kurman; Junji Moriya; Karen Dwyer; Mollie Leoni; Kevin Conlon; Lucy Cook; Jason Gonsky; Steven M Horwitz
Journal:  Haematologica       Date:  2018-12-20       Impact factor: 9.941

Review 4.  Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.

Authors:  Noriaki Yoshida; Kyohei Yamada; Koichi Ohshima
Journal:  Cancer Sci       Date:  2021-02-25       Impact factor: 6.716

Review 5.  Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.

Authors:  Adrienne A Phillips; Janine C K Harewood
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 4.213

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.